Mobile Trading

KWALITY PHARMACEUTICALS LTD.

NSE : NABSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1193.2564.4 (+5.7 %)
PREV CLOSE ( ) 1128.85
OPEN PRICE ( ) 1138.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 39514
TODAY'S LOW / HIGH ( )1109.35 1220.00
52 WK LOW / HIGH ( ) 483.11235
Managing DirectorRamesh Arora
Company SecretaryGurpreet Kaur
Non Executive Independent DirectorKiran Kumar Verma
Pankaj Takkar
Ravi Singh
Kartik Kapur
Prashanth Vellanki
Whole Time DirectorAjay Arora
Anju Arora
Geeta Arora
Aditya Arora
Incorporation Year : 04-05 1983

Registered Office :

Address : 6th Mile Stone,Village Nagkalan,Majitha Road Amritsar,
Punjab-143601 .

Phone : 08558820862 / 63 / 9915743720

Industry : Pharmaceuticals & Drugs

Listing : BSE

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.